A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: T-DM1|DRUG: Pembrolizumab
Sponsor: Dana-Farber Cancer Institute
Collaborators: Merck Sharp & Dohme LLC